Clinical Trial Update: Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children [Phase 2]

View source ↗

Summary

Phase 2 trial assessing immunogenicity and safety of the ChimeriVax Japanese Encephalitis Vaccine in Thai toddlers and children; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Japanese Encephalitis

Drugs mentioned

• ChimeriVax Japanese Encephalitis Vaccine (ChimeriVax JE vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Japanese Encephalitis, Hepatitis A | Phase 2 | Status: COMPLETED | Results posted: 2014-09-25